Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeNASDAQ

      NASDAQ

      Axcelis Technologies, Inc. Overbought in Morning Session
      Computer Hardware

      Axcelis Technologies, Inc. Overbought in Morning Session

      October 25, 2017
      Price Target Update on Spectrum Pharmaceuticals, Inc.
      Health

      Price Target Update on Spectrum Pharmaceuticals, Inc.

      October 24, 2017
      SunPower Corporation Registers a 2.84% Price Change After Morning Session
      Energy

      SunPower Corporation Registers a 2.84% Price Change After Morning Session

      October 24, 2017
      Head-to-Head: Axcelis Technologies VS Xcerra Corporation
      NASDAQ

      Head-to-Head: Axcelis Technologies VS Xcerra Corporation

      October 24, 2017
      Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter
      NASDAQ

      Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter

      October 24, 2017
      Head-to-Head: Impax Laboratories VS. SCYNEXIS
      Health

      Head-to-Head: Impax Laboratories VS. SCYNEXIS

      October 24, 2017
      Anavex Life Sciences Corp.: Top Holders Statistics
      Health

      Anavex Life Sciences Corp.: Top Holders Statistics

      October 23, 2017
      SunPower Corporation’s Rating Lowered by Zacks Investment Research
      Economy

      SunPower Corporation’s Rating Lowered by Zacks Investment Research

      October 23, 2017
      Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’
      Drug Manufacturers

      Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’

      October 20, 2017
      Is Impax Laboratories a Buy At $16?
      Health Services

      Is Impax Laboratories a Buy At $16?

      October 20, 2017
      « 1 2 3 4 5 6 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026